✦ LIBER ✦

Pluripotent human stem cells for the treatment of retinal disease

✍ Scribed by Teisha J. Rowland; David E. Buchholz; Dennis O. Clegg

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 121 KB
Volume: 227
Category: Article
ISSN: 0021-9541
DOI: 10.1002/jcp.22814

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Despite advancements made in our understanding of ocular biology, therapeutic options for many debilitating retinal diseases remain limited. Stem cell‐based therapies are a potential avenue for treatment of retinal disease, and this mini‐review will focus on current research in this area. Cellular therapies to replace retinal pigmented epithelium (RPE) and/or photoreceptors to treat age‐related macular degeneration (AMD), Stargardt's macular dystrophy, and retinitis pigmentosa are currently being developed. Over the past decade, significant advancements have been made using different types of human stem cells with varying capacities to differentiate into these target retinal cell types. We review and evaluate pluripotent stem cells, both human embryonic stem cells and human induced pluripotent stem cells, as well as protocols for differentiation of ocular cells, and culture and transplant techniques that might be used to deliver cells to patients. J. Cell. Physiol. 227: 457–466, 2012. © 2011 Wiley Periodicals, Inc.

📜 SIMILAR VOLUMES

Human pluripotent stem cells for disease

Human pluripotent stem cells for disease modelling and drug screening

✍ Yves Maury; Morgane Gauthier; Marc Peschanski; Cécile Martinat 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB 👁 2 views

## Abstract Considerable hope surrounds the use of disease‐specific pluripotent stem cells to generate models of human disease allowing exploration of pathological mechanisms and search for new treatments. Disease‐specific human embryonic stem cells were the first to provide a useful source for stu

An indicator for evaluating the risk of

An indicator for evaluating the risk of cancerous transformations of human induced pluripotent stem cells

✍ Hisashi Moriguchi; Raymond T. Chung; Chifumi Sato 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

copper alone, but with a large amount of copper incorporated into the not entirely characterized lysosomal complex of metallothionein polymers with a glycoprotein component, as supported by periodic acid-Schiff staining. We realized that copper-metallothionein autofluorescence was well-known in earl

Reprogramming the pluripotent cell cycle

Reprogramming the pluripotent cell cycle: Restoration of an abbreviated G1 phase in human induced pluripotent stem (iPS) cells

✍ Prachi N. Ghule; Ricardo Medina; Christopher J. Lengner; Matthew Mandeville; Men 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 461 KB 👁 1 views

## Abstract Induced pluripotent stem (iPS) cells derived from terminally differentiated human fibroblasts are reprogrammed to possess stem cell like properties. However, the extent to which iPS cells exhibit unique properties of the human embryonic stem (hES) cell cycle remains to be established. h

An identification of novel therapy for h

An identification of novel therapy for human hepatocellular carcinoma by using human induced pluripotent stem cells

✍ Hisashi Moriguchi; Raymond T. Chung; Chifumi Sato 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 1 views

Modeling and therapy of human liver dise

Modeling and therapy of human liver diseases using induced pluripotent stem cells: How far have we come?

✍ Alejandro Soto-Gutierrez; Edgar Tafaleng; Victoria Kelly; Jayanta Roy-Chowdhury; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB 👁 1 views

End-stage liver disease caused by chronic hepatitis C virus (HCV) infection is a leading cause for liver transplantation (LT). Due to viral evasion from host immune responses and the absence of preventive antiviral strategies, reinfection of the graft is universal. The mechanisms by which the virus

Transplantation of human embryonic stem

Transplantation of human embryonic stem cell-derived endothelial cells for vascular diseases

✍ Zongjin Li; Zhongchao Han; Joseph C. Wu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 1 views

## Abstract Using endothelial cells for therapeutic angiogenesis/vasculogenesis of ischemia diseases has led to exploring human embryonic stem cells (hESCs) as a potentially unlimited source for endothelial progenitor cells. With their capacity for self‐renewal and pluripotency, hESCs and their der